-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_1998_SummaryStats_CORE10B.PDF
January 01, 1998 - detachments, defects, vascular occlusion, and retinopathy 347 0.05
88: Glaucoma 68 0.01
89: Blindness and vision
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_1998_SummaryStats_CORE10A.PDF
January 01, 1998 - detachments, defects, vascular occlusion, and retinopathy 358 0.05
88: Glaucoma 54 0.01
89: Blindness and vision
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_1999_SummaryStats_CORE10A.pdf
January 01, 1999 - detachments, defects, vascular occlusion, and retinopathy 209 0.03
88: Glaucoma 37 0.01
89: Blindness and vision
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2013_MaskedStats_Core.PDF
January 01, 2013 - ; defects; vascular occlusion; and retinopathy 793 0.01%
88: Glaucoma 129 0.00%
89: Blindness and vision
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2011_MaskedStats_Core.PDF
January 01, 2011 - ; defects; vascular occlusion; and retinopathy 833 0.01%
88: Glaucoma 169 0.00%
89: Blindness and vision
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/CVoJ9fc9nv2Zsgs8R8XabH
September 01, 2022 - Symptoms of ocular syphilis include vision changes, decreased
visual acuity, and permanent blindness
-
hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2014_MaskedStats_Core.PDF
January 01, 2014 - defects; vascular occlusion; and retinopathy 1,557 0.01%
88: Glaucoma 331 0.00%
89: Blindness and vision
-
digital.ahrq.gov/sites/default/files/ahrq-dhr-2023-year-in-review.pdf
January 01, 2023 - The DHR Program’s vision is that every patient
and care team will have ready access to all
applicable
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_1999_SummaryStats.PDF
January 01, 1999 - detachments, defects, vascular occlusion, and retinopathy 2267 0.03
88: Glaucoma 415 0.01
89: Blindness and vision
-
hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2009_MaskedStats_Core.PDF
January 01, 2009 - detachments; defects; vascular occlusion; and retinopathy 547 0.02%
88: Glaucoma 26 0.00%
89: Blindness and vision
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cystic-fibrosis-hgh_appendixes.pdf
January 01, 2009 - health-related dimensions (physical condition/fitness, ability to
relax, energy/zest for life, mobility, vision
-
hcup-us.ahrq.gov/db/nation/nrd/Introduction_NRD_2019.pdf
January 01, 2019 - ;
and retinopathy 1,091 9.90 10.36 4.6
88: Glaucoma 274 13.14 13.50 2.8
89: Blindness and vision
-
hcup-us.ahrq.gov/db/nation/nrd/Introduction_NRD_2020.pdf
January 01, 2020 - ;
and retinopathy 1,091 9.90 10.36 4.6
88: Glaucoma 274 13.14 13.50 2.8
89: Blindness and vision
-
hcup-us.ahrq.gov/db/nation/nrd/Introduction_NRD_2010-2017.pdf
January 01, 2017 - ;
and retinopathy 1,091 9.90 10.36 4.6
88: Glaucoma 274 13.14 13.50 2.8
89: Blindness and vision
-
hcup-us.ahrq.gov/db/nation/nrd/Introduction_NRD_2020.jsp
January 01, 2020 - 1,091
9.90
10.36
4.6
88: Glaucoma
274
13.14
13.50
2.8
89: Blindness and vision
-
hcup-us.ahrq.gov/db/nation/nrd/Introduction_NRD_2010-2015.jsp
January 01, 2015 - 1,091
9.90
10.36
4.6
88: Glaucoma
274
13.14
13.50
2.8
89: Blindness and vision
-
hcup-us.ahrq.gov/db/nation/nrd/Introduction_NRD_2010-2016.pdf
January 01, 2016 - ;
and retinopathy 1,091 9.90 10.36 4.6
88: Glaucoma 274 13.14 13.50 2.8
89: Blindness and vision
-
digital.ahrq.gov/sites/default/files/docs/biblio/09-0054-EF-Updated_0.pdf
June 01, 2009 - Coordinator for Health
effective computerized reminder for contact Information Technology: President’s Vision
-
www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/overview/background/corebackgrnd.pdf
January 01, 2013 - Implementation of the set “as is” will not be sufficient to achieve the vision of a comparable,
evidence-based
-
www.ahrq.gov/sites/default/files/publications/files/ltcinstructor.pdf
June 01, 2012 - Diminished strength.
› Gait and balance impairments.
› Medications.
› Alzheimer’s disease or dementia.
› Vision